Clinical trial · Interventional
Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy
NCT04809727CI-TRIAL-00051079HSTHcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Supracervical hysterectomy is widely common and had many complications either immediate or delayed. In these patients bleeding, infection, chronic pelvic pain are common. In these patients cervical biopsy was done and histopathological examinations were done to evaluate the pathology in these patients.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer of Cervix | Malignant Cervical Neoplasm | ALIAS | 0.90 |
| Cervicitis | — | UNRESOLVED | — |
| CIN | Cervical Intraepithelial Neoplasia | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cervical biopsy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Biopsy
- description
- four quadrant biopsy
- interventionNames
- Procedure: Cervical biopsy
Primary outcomes (2)
- measure
- Detection of cervical neoplasia or cancer incidence
- timeFrame
- 1 year
- description
- Detection of number of cases diagnosed with cervical Cervical intraepithelial neoplasia, or malignancy by histopathological examination
- measure
- Detection of chronic cervicitis incidence
- timeFrame
- 1 year
- description
- Detection of number of cases diagnosed with inflammatory cells and other markers of inflammation
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: * all symptomatizing patients following supracervical hysterectomy, Exclusion Criteria: * with total hysterectomy, * hysterectomies for malignant indications, * refusal to participate.
References
Publications (0)
Data not yet available
No reference posted for this study.